GGrantIndex
← Leaderboards

Eugene M Johnson

Washington University

$5,512,165
Attributed
$5,512,165
Total exposure
5
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding mix

By agency

NIH$11,379,559 · 7

By mechanism

P01$3,725,393 · 2
R01$3,412,113 · 2
P50$2,667,778 · 1
R37$1,325,840 · 1
T32$248,435 · 1

Top collaborators

No co-investigators on record.

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Laboratory Mouse

Research focus

Laboratory MouseApoptosisNeurotrophic FactorsLaboratory RatSympathetic Nervous SystemNeuroprotectantsGliaNeuronsDenervationSciatic NerveLeukemia Inhibitory FactorNorthern BlottingsEmbryonic Stem CellNeural DegenerationNeuronal TransportSpinal Cord InjuryPolymerase Chain ReactionNeuropharmacologyStem Cell TransplantationGene MutationGene ExpressionMale CastrationAntisense Nucleic AcidGranule Cell

Grant awards (28)

Biology &Pharmaclogy of the GDNF Family of Ligands$385,000
R01 · FY2005 · AG
ES CELL TRANSPLANTATION AFTER SPINAL CORD INJURY$1,064,117
P01 · FY2004 · NS
Biology &Pharmaclogy of the GDNF Family of Ligands$385,000
R01 · FY2004 · AG
MECHANISM OF PROGRAMMED NEURONAL DEATH$276,859
R37 · FY2004 · AG
ES CELL TRANSPLANTATION AFTER SPINAL CORD INJURY$1,067,714
P01 · FY2003 · NS
Biology &Pharmaclogy of the GDNF Family of Ligands$385,000
R01 · FY2003 · AG
MECHANISM OF PROGRAMMED NEURONAL DEATH$270,839
R37 · FY2003 · AG
NEUROPROTECTIVE BAX MUTANTS--MECHANISM AND UTILITY$258,576
R01 · FY2003 · NS
ES CELL TRANSPLANTATION AFTER SPINAL CORD INJURY$1,067,785
P01 · FY2002 · NS
Biology &Pharmaclogy of the GDNF Family of Ligands$385,000
R01 · FY2002 · AG
MECHANISM OF PROGRAMMED NEURONAL DEATH$264,997
R37 · FY2002 · AG
NEUROPROTECTIVE BAX MUTANTS--MECHANISM AND UTILITY$252,743
R01 · FY2002 · NS
Apoptosis of ESNLCs$175,259
P01 · FY2002 · NS
Biology &Pharmaclogy of the GDNF Family of Ligands$385,000
R01 · FY2001 · AG
MECHANISM OF PROGRAMMED NEURONAL DEATH$259,325
R37 · FY2001 · AG
NEUROPROTECTIVE BAX MUTANTS--MECHANISM AND UTILITY$247,085
R01 · FY2001 · NS
Apoptosis of ESNLCs$175,259
P01 · FY2001 · NS
Alzheimer's Disease Research Center-Genetics Core$170,045
P50 · FY2001 · AG
BIOLOGY AND PHARMACOLOGY OF THE GDNF HOMOLOG NEURTURIN$121,138
R01 · FY2001 · AG
ALZHEIMER'S DISEASE RESEARCH CENTER$103,664
P50 · FY2001 · AG
NEUROPHARMACOLOGY RESEARCH TRAINING PROGRAM$79,972
T32 · FY2001 · NS
ALZHEIMER'S DISEASE RESEARCH CENTER$15,000
P50 · FY2001 · AG
ALZHEIMER'S DISEASE RESEARCH CENTER$2,379,069
P50 · FY2000 · AG
BIOLOGY AND PHARMACOLOGY OF THE GDNF HOMOLOG NEURTURIN$367,236
R01 · FY2000 · AG
MECHANISM OF PROGRAMMED NEURONAL DEATH$253,820
R37 · FY2000 · AG
NEUROPROTECTIVE BAX MUTANTS--MECHANISM AND UTILITY$240,335
R01 · FY2000 · NS
Apoptosis of ESNLCs$175,259
P01 · FY2000 · NS
NEUROPHARMACOLOGY RESEARCH TRAINING PROGRAM$168,463
T32 · FY2000 · NS